Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma

BACKGROUND: More than 50% of the worldwide cases of hepatocellular carcinoma occur in China, and this malignancy currently represents the country's second leading cause of cancer death in cities and the leading cause in rural areas. Despite recent advances in the control and management of hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Minshan, Therneau, Terry, Orsini, Lucinda S, Qiao, You-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115904/
https://www.ncbi.nlm.nih.gov/pubmed/21569429
http://dx.doi.org/10.1186/1471-230X-11-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115904/
https://www.ncbi.nlm.nih.gov/pubmed/21569429
http://dx.doi.org/10.1186/1471-230X-11-53

Ejemplares similares